Barely Significant
← all excerpts

Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls.

Ther Clin Risk Manag · 2014 · PMC3999277 · PMID 24790452

1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

did not achieve significanceP >0.05actually significant
40 Meanwhile, in a Japanese study including 557 primary breast cancer patients, although the T/T genotype tended to be associated with better disease-free survival compared to other genotypes of rs 2279744, this association did not achieve significance ( P >0.05), and no statistically significant correlation was found between prognosis and MDM2 rs 2279744 genotype. 41 The MDM2 promoter rs 2279744 polymorphism influences long-term survival among patients receiving paclitaxel for large primary breast cancers. 42 The relationship between the rs 2279744 polymorphism and cancer was inconsistent.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.